Blab AI
Butterfly Network Partners with Midjourney on 60-Second, Radiation-Free Full-Body Ultrasound Scanner
On June 18, Butterfly Network, Inc. (NYSE:BFLY) announced a partnership with Midjourney’s newly formed medical division to develop a full‑body imaging system that can scan the entire body in roughly 60 seconds. The plan blends Butterfly’s Ultrasound‑on‑Chip technology with Midjourney’s AI expertise, creating a device that promises to be both radiation‑free and free of magnetic risk.
The current prototype mounts 40 Ultrasound‑on‑Chip modules per system—a figure that the companies expect to grow as the platform scales. According to Butterfly’s press release, the scanner will incorporate about half a million sensors and more than two petaflops of processing power. CEO Joseph DeVivo called the device an “extraordinary whole‑body scanner” that could enable frequent, continuous monitoring of physiological changes.
Under the co‑development agreement, Butterfly will receive up to $74 million in payments over five years. The company said it backs Midjourney’s roadmap, seeing the partnership as a potential commercial opportunity. Butterfly’s existing product line—most notably the iQ Device and iQ+ portable ultrasound scanners—has focused on delivering real‑time, three‑dimensional imaging at a lower cost to physicians and other licensed health‑care providers.
Butterfly’s Ultrasound‑on‑Chip technology has made portable, affordable imaging possible, extending access beyond traditional cart‑based systems. Midjourney’s full‑body scanner aims to provide high‑resolution internal imaging faster and at a lower cost than conventional MRI, according to reports. If the prototype proves viable, the collaboration could accelerate the adoption of advanced imaging in clinical settings and improve early detection of abnormalities.
The scanner remains in prototype stage. Further development will require clinical validation, regulatory approvals, and market adoption. Butterfly’s involvement offers a pathway for scaling the technology, but the timeline for a commercial launch and the extent of regulatory clearance remain uncertain. The partnership exemplifies a growing trend of AI and semiconductor companies working together to deliver new medical imaging solutions.
The current prototype mounts 40 Ultrasound‑on‑Chip modules per system—a figure that the companies expect to grow as the platform scales. According to Butterfly’s press release, the scanner will incorporate about half a million sensors and more than two petaflops of processing power. CEO Joseph DeVivo called the device an “extraordinary whole‑body scanner” that could enable frequent, continuous monitoring of physiological changes.
Under the co‑development agreement, Butterfly will receive up to $74 million in payments over five years. The company said it backs Midjourney’s roadmap, seeing the partnership as a potential commercial opportunity. Butterfly’s existing product line—most notably the iQ Device and iQ+ portable ultrasound scanners—has focused on delivering real‑time, three‑dimensional imaging at a lower cost to physicians and other licensed health‑care providers.
Butterfly’s Ultrasound‑on‑Chip technology has made portable, affordable imaging possible, extending access beyond traditional cart‑based systems. Midjourney’s full‑body scanner aims to provide high‑resolution internal imaging faster and at a lower cost than conventional MRI, according to reports. If the prototype proves viable, the collaboration could accelerate the adoption of advanced imaging in clinical settings and improve early detection of abnormalities.
The scanner remains in prototype stage. Further development will require clinical validation, regulatory approvals, and market adoption. Butterfly’s involvement offers a pathway for scaling the technology, but the timeline for a commercial launch and the extent of regulatory clearance remain uncertain. The partnership exemplifies a growing trend of AI and semiconductor companies working together to deliver new medical imaging solutions.
